Literature DB >> 15645498

Two somatic biallelic lesions within and near SMAD4 in a human breast cancer cell line.

John Jakob1, Satoru Nagase, Adi Gazdar, Minchen Chien, Irina Morozova, James J Russo, Subhadra V Nandula, Vundavalli V V S Murty, Chi-Ming Li, Benjamin Tycko, Ramon Parsons.   

Abstract

Loss of chromosome arm 18q is a common event in human pancreatic, colon, and breast cancers and is often interpreted as representing loss of one or more tumor-suppressor genes. In this article, we describe two novel biallelic deletions at chromosome band 18q21.1 in a recently characterized human breast cancer cell line, HCC-1428. One lesion deletes a fragment of approximately 300 kb between SMAD4 and DCC that encodes no known genes. The second lesion is an in-frame SMAD4 deletion (amino acids 49-51) that affects the level of SMAD4 protein but not the SMAD4 message. This change accelerates 26S proteasome-mediated degradation of both endogenous and exogenous mutant SMAD4. Examination of normal DNA from the same patient demonstrated that both lesions are somatic and associated with loss of both normal alleles. These data support the concept that two independent tumor-suppressor loci exist at chromosome segment 18q21.1, one at SMAD4 and the other potentially at an enhancer of DCC or an unrelated novel gene. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645498     DOI: 10.1002/gcc.20142

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

Review 1.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

Review 2.  The complexities of TGF-β action during mammary and squamous cell carcinogenesis.

Authors:  Erin C Connolly; Rosemary J Akhurst
Journal:  Curr Pharm Biotechnol       Date:  2011-12       Impact factor: 2.837

3.  SMAD4 expression in breast ductal carcinoma correlates with prognosis.

Authors:  Nannan Liu; Chunyan Yu; Yanfen Shi; Jing Jiang; Yuhe Liu
Journal:  Oncol Lett       Date:  2015-07-01       Impact factor: 2.967

4.  Irs2 inactivation suppresses tumor progression in Pten+/- mice.

Authors:  Matthias Szabolcs; Megan Keniry; Laura Simpson; Latarsha J Reid; Susan Koujak; Sarah C Schiff; Giselle Davidian; Scott Licata; Sofia Gruvberger-Saal; Vundavalli V V S Murty; Subhadra Nandula; Argiris Efstratiadis; Jake A Kushner; Morris F White; Ramon Parsons
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

Review 5.  Complexities of TGF-β targeted cancer therapy.

Authors:  Erin C Connolly; Julia Freimuth; Rosemary J Akhurst
Journal:  Int J Biol Sci       Date:  2012-07-12       Impact factor: 6.580

6.  Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.

Authors:  Yongsheng Ren; Liyu Wu; Andra R Frost; William Grizzle; Xu Cao; Mei Wan
Journal:  Mol Cancer       Date:  2009-11-27       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.